During the last session, Cognition Therapeutics Inc (NASDAQ:CGTX)’s traded shares were 2.19 million, with the beta value of the company hitting 0.94. At the end
In the last trading session, 4.73 million shares of the Cognition Therapeutics Inc (NASDAQ:CGTX) were traded, and its beta was 1.01. Most recently the company’s
In the last trading session, 8.41 million shares of the Cognition Therapeutics Inc (NASDAQ:CGTX) were traded, and its beta was 1.17. Most recently the company’s
Cognition Therapeutics Inc (NASDAQ:CGTX)’s traded shares stood at 2.85 million during the last session, with the company’s beta value hitting 1.13. At the close of
In the last trading session, 3.88 million Cognition Therapeutics Inc (NASDAQ:CGTX) shares changed hands as the company’s beta touched 1.07. With the company’s per share
In last trading session, Cognition Therapeutics Inc (NASDAQ:CGTX) saw 32.17 million shares changing hands with its beta currently measuring 1.04. Company’s recent per share price
In recent trading session, Cognition Therapeutics Inc (NASDAQ:CGTX) saw 23.09 million shares changing hands at last check today with its beta currently measuring 1.04. Company’s
Cognition Therapeutics Inc (NASDAQ:CGTX) has a beta value of 1.24 and has seen 0.45 million shares traded in the recent trading session. The CGTX stock
During the last session, Cognition Therapeutics Inc (NASDAQ:CGTX)’s traded shares were 0.84 million, with the beta value of the company hitting 1.23. At the end
During the last session, Cognition Therapeutics Inc (NASDAQ:CGTX)’s traded shares were 1.59 million, with the beta value of the company hitting 1.25. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
